Rare diseases
Investigational molecules
Locations
Calle Balmes No 243 Escalera A Planta 5 Puerta 1, 08006 Barcelona, Spain
Research activity in colorectal cancer includes treatment strategies for advanced and refractory disease, with interest in immunotherapy, targeted therapy, and combinations with established chemotherapy backbones. The sponsor also supports work in molecularly defined disease, including DNA homologous-repair deficiency and metastatic disease with limited liver involvement.
These studies reflect a strong focus on systemic control of metastatic colorectal cancer and on improving outcomes in patients with poor-prognosis disease patterns.
Grupo Espanol Multidisciplinar En Cancer Digestivo runs clinical trials in conditions such as Rectal cancer, Anal squamous cell carcinoma, Colorectal cancer, Colorectal cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainSpainSpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
